Data Integrity in cGMP Drug Manufacturing: FDA Offers New Draft Guidance
The recent influx of concerns over data manipulation and other data integrity questions in India, China and elsewhere has pushed the US Food and Drug Administration (FDA) to put out new draft guidance to help the pharmaceutical industry ensure data is consistent and accurate.